150 related articles for article (PubMed ID: 9519908)
21. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
[TBL] [Abstract][Full Text] [Related]
22. Sulbactam-containing beta-lactamase inhibitor combinations.
Akova M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of sulbactam/ampicillin in children].
Ito S; Mayumi M; Ito M; Mikawa H
Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
[TBL] [Abstract][Full Text] [Related]
24. [Betalactamase inhibitors].
Timoşca S; Liscă M
Rev Med Chir Soc Med Nat Iasi; 1982; 86(1):35-41. PubMed ID: 25591246
[No Abstract] [Full Text] [Related]
25. Antibiotic resistance in Australia with special reference to sulbactam/ampicillin.
Fernandes CJ; Ackerman VP
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):153S-157S. PubMed ID: 2591174
[TBL] [Abstract][Full Text] [Related]
26. [Clinical efficacy of sulbactam/ampicillin in the field of pediatrics].
Ogura H; Hisakawa H; Kawakubo K; Kubota H; Shimanouchi Y; Matsumoto K; Tomoda T; Tone Y; Kurashige T
Jpn J Antibiot; 1989 Mar; 42(3):766-72. PubMed ID: 2746856
[TBL] [Abstract][Full Text] [Related]
27. [Clinical studies in sultamicillin fine granule in the field of pediatrics].
Sato Y; Ishikawa K; Iwata S; Akita H; Sunakawa K
Jpn J Antibiot; 1988 Dec; 41(12):1863-73. PubMed ID: 3249360
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
[TBL] [Abstract][Full Text] [Related]
29. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
Shibl AM
Chemotherapy; 1992; 38(5):324-9. PubMed ID: 1286574
[TBL] [Abstract][Full Text] [Related]
30. Escherichia coli resistant to ampicillin/sulbactam.
Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
[TBL] [Abstract][Full Text] [Related]
31. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
Pfaller MA; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Galante D; Esposito S; Barba D; Ruffilli MP
J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
[TBL] [Abstract][Full Text] [Related]
33. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
34. [The clinical and bacteriological efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating different infections].
Strachunskiĭ LS; Novikova IuA; Prokhorenkov PI; Iakusheva LV
Antibiot Khimioter; 1991 Jun; 36(6):18-21. PubMed ID: 1898183
[No Abstract] [Full Text] [Related]
35. Restricting the use of ampicillin-sulbactam.
Zavascki AP; Sandri AM
J Hosp Infect; 2004 Feb; 56(2):165-6. PubMed ID: 15019231
[No Abstract] [Full Text] [Related]
36. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
Heizmann WR; Heilmann F; Egeler B; Werner H
Infection; 1990; 18(2):117-21. PubMed ID: 2332245
[TBL] [Abstract][Full Text] [Related]
37. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
Leone F; Morandotti MG; Mazzella P; Sanna A; Ravizzola G; Colombrita D; Pinzi G; Turano R; Menozzi MG; Lecchini R
J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of antibiotics treatment in 86 cases of liver transplant recipients].
Liu ZG; Gong HY; Zhou JD; Zhang HY
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):852-5. PubMed ID: 19958647
[TBL] [Abstract][Full Text] [Related]
39. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Barcelona L; Marín M; Stamboulian D
Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
[TBL] [Abstract][Full Text] [Related]
40. Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase.
Livermore DM
J Antimicrob Chemother; 1992 Feb; 29(2):222-4. PubMed ID: 1506339
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
